文献速递泌尿生殖与妇科肿瘤放疗姑息放疗与转移瘤放疗物理与技术

转移性去势抵抗性前列腺癌骨转移患者的223Ra-二氯化物房室模型

Compartmental Model for 223Ra-Dichloride in Patients With Metastatic Bone Disease From Castration-Resistant Prostate Cancer.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2019-07-23

本研究基于6例接受2次110 kBq/kg 223Ra-二氯化物治疗的转移性去势抵抗性前列腺癌骨转移患者的活动滞留数据,构建了包含两个骨房室的房室模型。结果显示单骨房室不能准确描述骨骼活动滞留,加入第二骨房室后拟合改善且Akaike信息准则降低;患者间及治疗间速率常数无显著差异,提示基于患者测量的群体模型可行。

要点

  • 单骨房室模型不足以准确描述223Ra在骨骼中的活动滞留,需引入第二骨房室。
  • 血浆至第一骨房室及反向运输的平均速率常数分别为4.0和0.15 h⁻¹。
  • 第一至第二骨房室及反向运输的速率常数分别为0.03和0.008 h⁻¹。

核心结论

  • 223Ra-二氯化物 initially 定位于骨表面,随后相对快速地掺入骨基质,可能对剂量学和α辐射对正常骨组织效应的理解有启示。

研究设计与样本

  • 基于6例转移性去势抵抗性前列腺癌骨转移患者(2次治疗,每次110 kBq/kg 223Ra-二氯化物)的血浆、骨表面、小肠、大肠和排泄数据构建房室模型。

主要发现

  • 单骨房室不能准确描述骨骼活动滞留,加入第二骨房室后拟合改善且Akaike信息准则降低。
  • 血浆至第一骨房室及反向的平均速率常数分别为4.0(范围1.9-10.9)和0.15(0.07-0.39)h⁻¹。
  • 第一至第二骨房室及反向的速率常数分别为0.03(0.02-0.06)和0.008(0.003-0.011)h⁻¹。
  • 个体患者速率常数在患者间和治疗间无显著差异。

临床怎么用

  • 该模型提示223Ra-二氯化物先定位于骨表面后快速掺入骨基质,可用于优化剂量学评估和理解α辐射对正常骨组织的影响。
  • 基于患者测量的群体模型可行,支持未来个体化剂量学研究的模型框架。

局限性

  • 样本量小(6例患者),模型基于有限数据构建。
  • 未报告模型的外部验证或更大队列的确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: 223Ra-Dichloride is used for treatment of patients with metastatic bone disease from castration-resistant prostate cancer. The uptake and mechanism of action of 223Ra-Dichloride is not well understood. The aim of this work was to develop a compartmental model for 223Ra-Dichloride in patients to improve understanding of the underlying mechanisms. METHODS AND MATERIALS: A compartmental model was developed based on activity retention data from 6 patients (2 treatments of 110 kBq/kg 223Ra-Dichloride) for plasma, bone surfaces, small intestines, large intestines, and excretion data. Rate constants were extracted. Rate constant variability between patients and treatments was assessed. A population model was proposed and compared with the established International Commission on Radiological Protection-67 compartmental model. RESULTS: A single bone compartment cannot accurately describe activity retention in the skeleton. The addition of a second bone compartment improved the fit to skeleton retention data, and the Akaike information criterion decreased. Mean rate constants of 4.0 (range, 1.9-10.9) and 0.15 (0.07-0.39) h-1 were obtained for transport from plasma to first bone compartment and vice versa. Rate constants from first to second bone compartment and back of 0.03 (0.02-0.06) and 0.008 (0.003-0.011) h-1 were calculated. Rate constants for individual patients showed no significant difference between patients and treatments. CONCLUSIONS: The developed compartmental model suggests that 223Ra-Dichloride initially locates at the bone surface and is then incorporated into the bone matrix relatively quickly. This observation could have implications for dosimetry and understanding of the effects of alpha radiation on normal bone tissue. Results suggest that a population model based on patient measurements is feasible.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Taprogge J, Murray I, Gear J, et al. Compartmental Model for 223Ra-Dichloride in Patients With Metastatic Bone Disease From Castration-Resistant Prostate Cancer. Int J Radiat Oncol Biol Phys. 2019. PMID: 31349058. doi:10.1016/j.ijrobp.2019.07.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。